# OnCo record nct06834282 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06834282/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06834282", "NCT06834282" ;
  schema:name "CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)"@en ;
  schema:description "A phase 1 trial of CER-1236 run by CERo Therapeutics Holdings, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06834282/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06834282> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/primary-myelofibrosis/> ;
  onco:drugs <https://onco.cc/drugs/cer-1236/> ;
  onco:companies <https://onco.cc/companies/cero-therapeutics/> .